Optimal Treatment for Hypertension in Patients at Risk for Cardiovascular Disease: A New Perspective
Frank A. Laws, M.D.
, and Richard W. Smalling, M.D., Ph.D.
Dr. Laws is from the Division of Cardiology, Department of Medicine, The University of Texas Medical School at Houston and Memorial Hermann Hospital, Houston, Texas.
During the past three years, Dr. Smalling has received grant/research support from Centocor, Cordis, Boston Scientific and Merck. Dr. Laws reports no commercial conflict of interest.
This activity is made possible by an unrestricted educational grant from
Estimated time to complete:
Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Upon completion of this Cyberounds®
, you should be able to:
- Identity which parameter of blood pressure yields the best prognostic information in hypertensive patients at risk for cardiovascular disease
- Identify the blood pressure profiles that represent the best therapeutic goals in hypertensive patients who are at risk for the development of cardiovascular disease
- Discuss why evaluation of other indices of arterial load and stiffness can lead to the early identification and treatment of patients at risk for the development of cardiovascular disease.